The Assignment of the Reactive Sites of the Double-headed
Arrowhead Proteinase Inhibitor A and B

LI Jiong, RUAN Kang-Cheng, CHI Cheng-Wu*
( Laboratory of Proteomics, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences,
the Chinese Academy of Sciences, Shanghai 200031, China )

Abstract    The arrowhead proteinase inhibitor A and B (APIA and APIB) are double-headed and multifunctional. Both their primary structure and cDNA sequence have been elucidated. To locate the possible reactive site residues Lys44, Arg76 and Arg87 of APIB predicted according to the sequence comparison with other proteinase inhibitors, the above residues were substituted with Pro by site-directed mutagenesis respectively, and the mutated genes were expressed in the yeast secretion system. The mutant K44P-APIB displayed the same inhibitory activity as APIB does, while the mutants R76P-APIB and R87P-APIB could only inhibit one molecule, instead of two molecules of trypsin, indicating that Arg76 and Arg87 but not Lys44 are the two reactive sites of APIB. In order to further confirm this result , more mutants of APIB (K44P-R76P-APIB, K44P-R87P-APIB,ª©R76P-R87P-APIB) were designed, in each mutant only one of the three possible reactive sites remained unchanged. Both the mutants K44P-R76P-APIB and K44P-R87P-APIB could only inhibit one molecule of trypsin, while R76P-R87P-APIB could no longer inhibit trypsin intensively, thus the residues Arg76 and Arg87 are definitely the reactive sites of APIB. Their Ki were measured to be 0.39 nmol/L and 0.47 nmol/L, respectively. The mutant R87L-APIB lost about half activity towards trypsin but could inhibit one molecule of chymotrypsin as the wide type APIA did, indicating that Leu87 was the reactive site towards trypsin but could inhibit one molecule of APIA for inhibiting chymotrypsin.
Key words    arrowhead proteinase inhibitor
£» siteª²directed mutagenesis£» inhibitory activity£» reactive site

*Corresponding author£º Tel, 86-21-64374430; Fax, 86-21-64338357; e-mail, [email protected]